SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opko Health, Inc. – ‘10-Q’ for 6/30/17 – ‘R50’

On:  Tuesday, 8/8/17, at 4:15pm ET   ·   For:  6/30/17   ·   Accession #:  944809-17-8   ·   File #:  1-33528

Previous ‘10-Q’:  ‘10-Q’ on 5/10/17 for 3/31/17   ·   Next:  ‘10-Q’ on 11/8/17 for 9/30/17   ·   Latest:  ‘10-Q’ on 5/7/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/08/17  Opko Health, Inc.                 10-Q        6/30/17   75:8.9M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    648K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
12: R1          Document and Entity Information                     HTML     40K 
13: R2          Condensed Consolidated Balance Sheets               HTML    100K 
14: R3          Condensed Consolidated Balance Sheets               HTML     30K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statements of Operations     HTML     94K 
16: R5          Condensed Consolidated Statements of Comprehensive  HTML     41K 
                Income (Loss)                                                    
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    124K 
18: R7          Business and Organization                           HTML     28K 
19: R8          Summary of Significant Accounting Policies          HTML     77K 
20: R9          Earnings (Loss) Per Share                           HTML     78K 
21: R10         Composition of Certain Financial Statement          HTML    122K 
                Captions                                                         
22: R11         Acquisitions, Investments and Licenses              HTML     60K 
23: R12         Debt                                                HTML    125K 
24: R13         Accumulated Other Comprehensive Income (Loss)       HTML     38K 
25: R14         Fair Value Measurements                             HTML    140K 
26: R15         Derivative Contracts                                HTML     54K 
27: R16         Related Party Transactions                          HTML     35K 
28: R17         Commitments and Contingencies                       HTML     32K 
29: R18         Strategic Alliances                                 HTML     50K 
30: R19         Segments                                            HTML    153K 
31: R20         Subsequent Events                                   HTML     23K 
32: R21         Summary of Significant Accounting Policies          HTML    136K 
                (Policies)                                                       
33: R22         Earnings (Loss) Per Share (Tables)                  HTML     72K 
34: R23         Composition of Certain Financial Statement          HTML    123K 
                Captions (Tables)                                                
35: R24         Acquisitions, Investments and Licenses (Tables)     HTML     48K 
36: R25         Debt (Tables)                                       HTML    110K 
37: R26         Accumulated Other Comprehensive Income (Loss)       HTML     38K 
                (Tables)                                                         
38: R27         Fair Value Measurements (Tables)                    HTML    141K 
39: R28         Derivative Contracts (Tables)                       HTML     55K 
40: R29         Segments (Tables)                                   HTML    151K 
41: R30         Business and Organization (Details)                 HTML     34K 
42: R31         Summary of Significant Accounting Policies          HTML    130K 
                (Details)                                                        
43: R32         Earnings (Loss) Per Share - Schedule of Earnings    HTML     59K 
                Per Share (Details)                                              
44: R33         Earnings (Loss) Per Share - Narrative (Details)     HTML     33K 
45: R34         Composition of Certain Financial Statement          HTML    138K 
                Captions (Details)                                               
46: R35         Composition of Certain Financial Statement          HTML     57K 
                Captions - Changes in Goodwill (Details)                         
47: R36         Acquisitions, Investments and Licenses -            HTML     32K 
                Acquisition Narrative (Details)                                  
48: R37         Acquisitions, Investments and Licenses -            HTML     44K 
                Transition Therapeutics Purchase Price Allocation                
                (Details)                                                        
49: R38         Acquisitions, Investments and Licenses - Summary    HTML     37K 
                of Investments (Details)                                         
50: R39         Acquisitions, Investments and Licenses - Equity     HTML     57K 
                and Cost Method Investments Narrative (Details)                  
51: R40         Acquisitions, Investments and Licenses - Available  HTML     51K 
                for Sale Investments, Sale of Investments and                    
                Warrants and Options Narrative (Details)                         
52: R41         Acquisitions, Investments and Licenses - Variable   HTML     33K 
                Interest Entities Narrative (Details)                            
53: R42         Acquisitions, Investments and Licenses - Other      HTML     40K 
                Narrative (Details)                                              
54: R43         Debt - Narrative (Details)                          HTML    143K 
55: R44         Debt - Notes (Details)                              HTML     51K 
56: R45         Debt - Inputs Used In Lattice Model (Details)       HTML     40K 
57: R46         Debt - Fair Value Of Embedded Derivatives           HTML     28K 
                (Details)                                                        
58: R47         Debt - Lines Of Credit (Details)                    HTML     60K 
59: R48         Debt - Mortgage Notes And Other Debt (Details)      HTML     31K 
60: R49         Accumulated Other Comprehensive Income (Loss)       HTML     43K 
                (Details)                                                        
61: R50         Fair Value Measurements - Summary Of Investments    HTML     35K 
                (Details)                                                        
62: R51         Fair Value Measurements - Assets And Liabilities    HTML     54K 
                Measured At Fair Value (Details)                                 
63: R52         Fair Value Measurements - Notes (Details)           HTML     29K 
64: R53         Fair Value Measurements - Level 3 Reconciliation    HTML     36K 
                (Details)                                                        
65: R54         Fair Value Measurements - Narrative (Details)       HTML     33K 
66: R55         Derivative Contracts - Balance Sheet Component      HTML     39K 
                (Details)                                                        
67: R56         Derivative Contracts - Derivative Gains (Losses)    HTML     32K 
                (Details)                                                        
68: R57         Related Party Transactions (Details)                HTML    164K 
69: R58         Commitments and Contingencies (Details)             HTML     36K 
70: R59         Strategic Alliances (Details)                       HTML    104K 
71: R60         Segments - Narrative (Details)                      HTML     41K 
72: R61         Segments - Operations and Assets Information        HTML     78K 
                (Details)                                                        
74: XML         IDEA XML File -- Filing Summary                      XML    132K 
73: EXCEL       IDEA Workbook of Financial Reports                  XLSX    106K 
 6: EX-101.INS  XBRL Instance -- opk-20170630                        XML   2.77M 
 8: EX-101.CAL  XBRL Calculations -- opk-20170630_cal                XML    251K 
 9: EX-101.DEF  XBRL Definitions -- opk-20170630_def                 XML    971K 
10: EX-101.LAB  XBRL Labels -- opk-20170630_lab                      XML   1.93M 
11: EX-101.PRE  XBRL Presentations -- opk-20170630_pre               XML   1.20M 
 7: EX-101.SCH  XBRL Schema -- opk-20170630                          XSD    180K 
75: ZIP         XBRL Zipped Folder -- 0000944809-17-000008-xbrl      Zip    290K 


‘R50’   —   Fair Value Measurements – Summary Of Investments (Details)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.7.0.1
Fair Value Measurements - Summary Of Investments (Details) - USD ($)
$ in Thousands
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost $ 2,815 $ 3,409
Gross unrealized gains in Accumulated OCI 1,152 1,313
Gross unrealized losses in Accumulated OCI (182) (194)
Fair value 3,785 4,528
Common stock investments, available for sale    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 2,815 3,409
Gross unrealized gains in Accumulated OCI 1,152 1,313
Gross unrealized losses in Accumulated OCI (182) (194)
Fair value $ 3,785 $ 4,528

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/8/174,  8-K
For Period end:6/30/174
12/31/1610-K,  SD
 List all Filings 
Top
Filing Submission 0000944809-17-000008   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 12:44:08.1pm ET